HEM Hemostemix Inc.

0.0210USD0.0300 CAD · TSXV-14.29%Mkt Cap: 4.43M USDP/E: —

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which completed Phase II…